Scroll back to top

Alport Syndrome (NGS Panel and Copy Number Analysis)

CPT: 81407 (x2), 81408 (x2), 81479 (x1)

Special Instructions

Test orders should now be placed through Labcorp using test code 631087
 


Genes Assessed


Specimen Requirements


Specimen

Whole blood, oral swab, extracted DNA (from blood or oral swab only)


Volume

Whole blood: 4 ml
Oral swab: 3 swabs
Extracted DNA: Contact MNG Genetic Services 844-664-8378 (844-MNGTEST) 


Minimum Volume

Whole blood: 2 ml
Oral swab: 1 swab
Extracted DNA: Contact MNG Genetic Services 844-664-8378 (844-MNGTEST)


Container

Whole blood: Lavender-top (EDTA) 
Oral swab: OCD-100 DNA Genotek
Extracted DNA: Contact MNG Genetic Services 844-664-8378 (844-MNGTEST)


Collection

Whole blood: standard phlebotomy. 
Oral swab: follow kit instructions
Extracted DNA: Contact MNG Genetic Services 844-664-8378 (844-MNGTEST)


Storage Instructions

Maintain specimen at room temperature or refrigerate at 4°C. Do not freeze. 


Stability Requirements

• Room temperature: Whole blood: 14 days; Swab: 60 days
• Refrigerated: Whole blood: 30 days; Swab: 60 days
• Frozen: Do not freeze


Causes for Rejection

Frozen or hemolyzed specimen; quantity not sufficient for analysis; improper container


Test Details


Limitations

This assay will not consistently detect mosaicism or rule out the presence of large chromosomal aberrations, including rearrangements and inversions that do not change copy number of genomic regions. This NGS assay does not detect repeat expansions. False positive or false negative results may occur for reasons that include insufficient information available about rare genetic variants, sex chromosome abnormalities, pseudogene interference, homologous regions, blood transfusions, bone marrow transplantation, somatic or tissue-specific mosaicism/heteroplasmy, mislabeled samples, or erroneous representation of family relationships. For panels with mitochondrial DNA assessment, low levels of heteroplasmy may not be reliably detected. Interpretation of the clinical significance of gene variations is limited by information about the variant that is available at the time of reporting, and by the quality and quantity of clinical information provided with the sample. The interpretation of the clinical significance of variants may change.

This test was developed and its performance characteristics determined by Labcorp. It has not been cleared or approved by the Food and Drug Administration.


Methodology

Next-generation sequencing to identify genetic variants, including single nucleotide variants (SNVs), insertions, deletions, and copy number variants (CNVs). 


Recommended MNG Kits

SINGLE Blood Genetic Testing, Buccal Swab Genetic Testing